H Chih-Ho Hong

22PUBLICATIONS
98CO-AUTHORS
AllergyGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Adolescent healthTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Oct 22, 2026
Lebrikizumab Provides Stable and Deep Long-Term Response with No/Minimal Fluctuations up to 3 Years in Patients with Moderate-to-Severe Atopic Dermatitis.

|Sep 12, 2026
Real-World Evidence of Upadacitinib in Atopic Dermatitis after Inadequate Response or Intolerance to Dupilumab: The CAN UpTIMISE Study.

|Jul 20, 2026
Ruxolitinib cream in adults with moderate atopic dermatitis after failure of other topicals: A randomized trial.

|May 27, 2026
Safety and Tolerability of Ruxolitinib Cream in Adolescents with Mild-to-Moderate Atopic Dermatitis: Results From a 1-Year, Phase III, Open-Label Study.

|Mar 19, 2026
Current and Future Management of Chronic Hand Eczema in Canada: Evolving Treatment Paradigms.

Jensen Yeung, Melinda Gooderham, H Chih-Ho Hong

|Feb 05, 2026
Long-Term Safety and Efficacy of Tralokinumab in Patients with Moderate-to-Severe Atopic Dermatitis Treated for up to 6 Years: Final Results from the Open-Label Extension Trial ECZTEND.

Andrew Blauvelt, H Chih-Ho Hong, Norito Katoh

Pageof 4

Frequent Collaborators

10 joint publications

Melinda J Gooderham

7 joint publications

Ronald Vender

7 joint publications

Kim Papp

7 joint publications

Vimal H Prajapati